Previous studies have demonstrated that low CD4 + /CD8 + ratio is a crucial indicator of the severity and poor prognosis of malignant tumors, with a lower ratio indicating a higher risk of tumor metastasis and recurrence31. This evidence concerns the gene CD4 and neoplasm.